Egypt's health ministry yesterday announced the nation's fourth H5N1 case of the year, which involves a 34-year-old from Minya who is hospitalized and on a ventilator, according to a report today from the Middle East News Agency (MENA).
The US Food and Drug Administration (FDA) has approved tedizolid phosphate (Sivextro), a new antibacterial drug to treat adults with acute bacterial skin and skin structure infections (ABSSSI), the agency announced on Jun 20.
The flu vaccine in three European nations in 2012-13 provided 33% protection against hospitalization for influenza in adults, according to a study yesterday in PLoS One.
Is there a unique public health benefit of gain-of-function studies, unachievable by safer means, that outweighs their risk?
A fatal case of H5N1 avian flu has been reported in Indonesia, according to a story in the Jakarta Post today. This represents the second confirmed human case of the highly pathogenic strain of avian influenza in the country this year.
The World Health Organization (WHO) yesterday said it is working with local and international health partners in Iraq to address pressing concerns—including measles and polio risks—of populations hit hard by recent instability there.
The second H7N9 wave not only had many more cases than the first, it affected a wider area.
Avian influenza viruses with components similar to those in the 1918 pandemic flu virus still circulate in nature, and genetic engineering experiments suggest it would take only a few mutations to turn them into a human threat, according to a team of scientists led by Yoshiro Kawaoka, DVM, PhD, of the University of Wisconsin.
The risk of post-vaccination seizures in 1-year-olds was twice as high with the combined measles-mumps-rubella-varicella (MMRV) vaccine compared with the MMR and varicella vaccines (MMR+V) administered separately, but the absolute risk is small, according to a study yesterday in the Canadian Medical Association Journal (CMAJ).
Both urban and rural residents in China interviewed in late spring and early summer last year—after the spring peak in H7N9 cases—reported fairly high exposure to poultry but fairly low anxiety about the disease, according to a study yesterday in Emerging Infectious Diseases.
